| TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes JS Welch, AA Petti, CA Miller, CC Fronick, M O’Laughlin, RS Fulton, ... New England Journal of Medicine 375 (21), 2023-2036, 2016 | 896 | 2016 |
| Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen TN Christ, W Stock, RW Knoebel Journal of Oncology Pharmacy Practice 24 (4), 299-308, 2018 | 53 | 2018 |
| Treatment disparities among the Black population and their influence on the equitable management of chronic pain RW Knoebel, JV Starck, P Miller Health Equity 5 (1), 596-605, 2021 | 45 | 2021 |
| Does adherence to National Comprehensive Cancer Network guidelines improve pain-related outcomes? An evaluation of inpatient cancer pain management at an academic medical center M Mearis, JW Shega, RW Knoebel Journal of Pain and Symptom Management 48 (3), 451-458, 2014 | 40 | 2014 |
| Evaluation of a low, weight-based dose of rasburicase in adult patients for the treatment or prophylaxis of tumor lysis syndrome RW Knoebel, M Lo, CW Crank Journal of Oncology Pharmacy Practice 17 (3), 147-154, 2011 | 38 | 2011 |
| Efficacy and toxicity of reduced vs. standard dose pegylated asparaginase in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia BA Derman, M Streck, J Wynne, TN Christ, E Curran, W Stock, ... Leukemia & lymphoma 61 (3), 614-622, 2020 | 36 | 2020 |
| Efficacy of single-agent decitabine in relapsed and refractory acute myeloid leukemia N Khan, A Hantel, RW Knoebel, A Artz, RA Larson, LA Godley, ... Leukemia & Lymphoma 58 (9), 2127-2133, 2017 | 26 | 2017 |
| Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia M Vicente, M Al-Nahedh, S Parsad, RW Knoebel, J Pisano, NN Pettit Journal of Oncology Pharmacy Practice 23 (8), 575-581, 2017 | 21 | 2017 |
| The ImPreSS trial: implementation of point-of-care pharmacogenomic decision support in perioperative care TM Truong, J Apfelbaum, S Shahul, M Anitescu, K Danahey, RW Knoebel, ... Clinical pharmacology and therapeutics 106 (6), 1179, 2019 | 19 | 2019 |
| Posaconazole–digoxin drug–drug interaction mediated by inhibition of P-glycoprotein AC Shumaker, HM Bullard, J Churpek, RW Knoebel Journal of Oncology Pharmacy Practice 25 (7), 1758-1761, 2019 | 17 | 2019 |
| Pepsi® or Coke®? Influence of acid on dasatinib absorption RW Knoebel, RA Larson Journal of oncology pharmacy practice 24 (2), 156-158, 2018 | 17 | 2018 |
| Alternative trastuzumab dosing strategies in HER2-positive early breast cancer are associated with patient out-of-pocket savings PH Hsieh, AJ Kacew, M Dreyer, AV Serritella, RW Knoebel, ... NPJ Breast Cancer 8 (1), 32, 2022 | 16 | 2022 |
| Changes in intravenous immunoglobulin usage for hypogammaglobulinemia after implementation of a stewardship program BA Derman, Z Schlei, S Parsad, K Mullane, RW Knoebel JCO oncology practice 17 (3), e445-e453, 2021 | 15 | 2021 |
| Pharmacogenomic considerations for medications in the perioperative setting EH Jhun, JL Apfelbaum, DM Dickerson, S Shahul, R Knoebel, K Danahey, ... Pharmacogenomics 20 (11), 813-827, 2019 | 12 | 2019 |
| Impact of a clinical decision support tool on cancer pain management in opioid-tolerant inpatients TN Christ, JJ Villadolid, A Choksi, M Malec, RW Knoebel Hospital pharmacy, 0018578717746369, 2018 | 12 | 2018 |
| Alternative trastuzumab dosing schedules are associated with reductions in health care greenhouse gas emissions SI Jacobson, AJ Kacew, RW Knoebel, PH Hsieh, MJ Ratain, ... JCO Oncology Practice 19 (9), 799-807, 2023 | 10 | 2023 |
| Implementation of pharmacogenomics into inpatient general medicine T Chen, PH O’Donnell, M Middlestadt, GW Ruhnke, K Danahey, ... Pharmacogenetics and genomics 33 (2), 19-23, 2023 | 9 | 2023 |
| Medication management in older adults and interprofessional education: a needs assessment T Kostas, R Knoebel, S Levine Gerontology & Geriatrics Education 41 (1), 100-108, 2020 | 9 | 2020 |
| Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing YM Lee, K Danahey, RW Knoebel, MJ Ratain, DO Meltzer, PH O’Donnell Pharmacogenetics and Genomics 29 (2), 23-30, 2019 | 9 | 2019 |
| Impact of COVID-19 pandemic, social vulnerability, and opioid overdoses in Chicago RW Knoebel, SJ Kim AJPM focus 2 (2), 100086, 2023 | 6 | 2023 |
Mark RatainLeon O. Jacobson Professor of Medicine, The University of ChicagoZweryfikowany adres z uchicago.edu